Cyclosporine in treatment of progressive systemic sclerosis: clinical and immunologic findings.
Ippoliti
G
G
Clinica Medica II, IRCCS S. Matteo, Università di Pavia, Italy.
Miori
L
L
Negri
M
M
Rovati
B
B
Lorenzutti
F
F
Zerbinati
N
N
Rabbiosi
G
G
D015703:Antigens, CD / Q000097:blood; D015214:Antigens, Differentiation, Myelomonocytic / Q000096:biosynthesis; D001706:Biopsy; D002448:Cell Adhesion; D015815:Cell Adhesion Molecules / Q000096:biosynthesis; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D019040:E-Selectin; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000096:biosynthesis / Q000097:blood; D008297:Male; D008875:Middle Aged; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D012867:Skin / Q000276:immunology / Q000473:pathology
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D015815:Cell Adhesion Molecules; D019040:E-Selectin; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1; D016572:Cyclosporine